Download FREE Report Sample
Download Free sampleTestosterone undecanoate is the ester prodrug of testosterone and has a midchain fatty acid at the 17Beta position.It is available as an intramuscular injection and as an oral capsule, and is indicated for treatment of testosterone deficiency.
Testosterone Undecylate Market contains market size and forecasts of Testosterone Undecylate (TU) in Global, including the following market information:
Global Testosterone Undecylate (TU) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Testosterone Undecylate (TU) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Testosterone Undecylate (TU) include Organon, Bayer AG, Endo Pharmaceuticals, Merck Sharp & Dohme, Taro Pharmaceutical, Cipla, Clarus Therapeutics, Zhejiang Xianju Pharmaceutical and Zhejiang Medicine. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Testosterone Undecylate (TU) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Testosterone Undecylate (TU) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Testosterone Undecylate (TU) Market Segment Percentages, by Type, 2021 (%)
Injection
Oral
Global Testosterone Undecylate (TU) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Testosterone Undecylate (TU) Market Segment Percentages, by Application, 2021 (%)
Primary Hypogonadism
Hypogonadotropic Hypogonadism
Late-Onset Hypogonadism
Global Testosterone Undecylate (TU) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Testosterone Undecylate (TU) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Testosterone Undecylate (TU) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Testosterone Undecylate (TU) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Organon
Bayer AG
Endo Pharmaceuticals
Merck Sharp & Dohme
Taro Pharmaceutical
Cipla
Clarus Therapeutics
Zhejiang Xianju Pharmaceutical
Zhejiang Medicine
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
